Warning: file_put_contents(c/01c13908b53b82a69797069bf9c9de50.php): Failed to open stream: No space left on device in /home/w/04uk/_____/f.php on line 139
Dr Arvind R Shah Limited, N12 9RT Company Information, Office Address, Contact, Directors & Officers, Accounts, Statements and Filing History : UKBizDB.co.uk
UKBizDB.co.uk

DR ARVIND R SHAH LIMITED

PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)

This company is commonly known as Dr Arvind R Shah Limited. The company was founded 11 years ago and was given the registration number 08735854. The firm's registered office is in LONDON. You can find them at 930 High Road, , London, . This company's SIC code is 86220 - Specialists medical practice activities.

Company Information

Name:DR ARVIND R SHAH LIMITED
Company Number:08735854
Company Type:PRI/LTD BY GUAR/NSC (Private, limited by guarantee, no share capital)
Status:Active
Incorporation Date:17 October 2013
End of financial year:31 March 2024
Jurisdiction:England - Wales
Industry Codes:
  • 86220 - Specialists medical practice activities

Office Address & Contact

Registered Address:930 High Road, London, N12 9RT
Country Origin:
Telephone:Unreported
Email Address:Unreported
Website:Unreported
Social:Unreported

Company Officers

Personal InformationRoleAppointedStatus
930, High Road, London, United Kingdom, N12 9RT

Director17 October 2013Active

People with Significant Control

Dr Arvind Rasiklal Shah
Notified on:06 April 2016
Status:Active
Date of birth:January 1955
Nationality:British
Address:930, High Road, London, N12 9RT
Nature of control:
  • Ownership of shares 75 to 100 percent
  • Voting rights 75 to 100 percent
  • Right to appoint and remove directors

Account Documents

Accounts

  • Last accounts submitted for period 31 March 2023 (1 year ago)
  • Accounts type was MICRO
  • Next accounts dated 31 March 2024
  • Due by 31 December 2024 (1 months remaining)

Confirmation Statement

  • Last submitted on 14 October 2023 (1 year ago)
  • Next confirmation dated 14 October 2024
  • Due by 28 October 2024 (0 months remaining)

Copyright © 2024. All rights reserved.